JENNIFER ZAVALA: Open Payments
NPI 1184904336 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,204 in 127 payments from 21 companies in 2025. Trend: 2023 $4,479 · 2024 $4,137 · 2025 $3,204
Food & beverage: $3,105Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $573 |
| Amgen Inc. | 31 | $429 |
| Janssen Biotech, Inc. | 16 | $409 |
| UCB, Inc. | 10 | $335 |
| ABBVIE INC. | 2 | $300 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $284 |
| ANI Pharmaceuticals, Inc. | 8 | $168 |
| Mallinckrodt Hospital Products Inc. | 7 | $130 |
| AstraZeneca Pharmaceuticals LP | 4 | $128 |
| PFIZER INC. | 6 | $92 |
Products named: COSENTYX, TREMFYA, Bimzelx, RINVOQ, PURIFIED CORTROPHIN GEL, OTEZLA, KRYSTEXXA, ACTHAR.
Industry payments across TX — which companies pay providers there.
